The new food is important because it likely contains L-DOPA, a precursor to dopamine. While this might be an attempt by the patient to self-medicate the parkinsonian side effects of her primary medication, increasing dopamine levels is highly likely to counteract her antipsychotic treatment and cause a severe relapse of her schizophrenic symptoms (psychosis).